Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.
Zahra KianiNadereh KhorsandFahimeh BeigiGholamreza AskariManoj SharmaMohammad BagherniyaPublished in: Trials (2024)
Results showed that in patients with burn injury, CoQ10 administration had no effect on inflammatory markers and oxidative stress, although serum albumin levels were improved after supplementation. Further studies with albumin as the primary outcome are needed to confirm this finding.
Keyphrases
- oxidative stress
- end stage renal disease
- newly diagnosed
- ejection fraction
- double blind
- chronic kidney disease
- placebo controlled
- prognostic factors
- randomized controlled trial
- clinical trial
- ischemia reperfusion injury
- induced apoptosis
- phase ii
- phase ii study
- open label
- endoplasmic reticulum stress
- case control
- heat shock